guest :: login
DKFZ
    Search   Submit  
Personalize
  • Your alerts
  • Your baskets
  • Your searches
  Help    
Home > Publications database > Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial > Access to Fulltext
  • Information
  • Files
 
 
Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial - DKFZ-2026-01474
 
Main document file(s):
      Intl Journal of Cancer - 2026 - Hille - Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for
    version 1
    Intl Journal of Cancer - 2026 - Hille - Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for.pdf [708.12 KB] 04 Nov 2026, 10:55 OpenAccess
    Intl Journal of Cancer - 2026 - Hille - Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for.pdf (pdfa) [915.71 KB] 04 Nov 2026, 10:55 OpenAccess
Similar records

DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2610
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy